Effects of tirzepatide, a novel dual GIP and GLP-1 receptor agonist, on metabolic profile in patients with type 2 diabetes

V. Pirro, J. A. Willency,J. M. Wilson,K. D. Roth,Y. Lin, K. A. L. Collins,G. Ruotolo,A. Haupt, C. B. Newgard, K. L. Duffin

DIABETOLOGIA(2020)

引用 3|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要